- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2025–2026 · grant · Flint Area / Revitalizing the Education Continuum
Operating Support
Kettering University · funded by Charles Stewart Mott Foundation
2025–2028 · grant · Standard Grant
Explorations: Bringing High School Students and GED Earners into Artificial Intelligence Career Pathways
Diane Peters · Kettering University · funded by National Science Foundation
2025–2027 · research · R21
Role of Mast cells in regulating inflammatory pathology of secondary lymphedema
Raghu Prasad Kataru · Kettering University · funded by National Institutes of Health
2025 · research · Research
Understanding Feasibility of Using Large Language Models to Enhance Patient-Reported Outcomes
Thomas Atkinson · Kettering University · funded by Patient-Centered Outcomes Research Institute
2025–2030 · research · R01
DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung Cancer
Adam J Schoenfeld · Kettering University · funded by National Institutes of Health
2025–2028 · fellowship · F31
Understanding how appropriate apoptotic cell degradation ensures lung homeostasis
Achuth Nair · Kettering University · funded by National Institutes of Health
2025–2030 · research · R37
Leveraging Radiation-Induced Senescence and PTPN2 Inhibition to Enhance Immune-Mediated Tumor Control in Rectal Cancer
Paul Bernard Romesser · Kettering University · funded by National Institutes of Health
2025–2028 · career development · K00
Engineering Biomaterials to Modulate the Tumor Immune Microenvironment
Christian Gabriel Figueroa-Espada · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Approaches for engineering transcriptional state of fibroblasts and other differentiated cell types
Thomas Maxwell Norman · Kettering University · funded by National Institutes of Health
2025–2027 · research · R37
Regulation of tumor suppression by alpha-ketoglutarate
Lydia Finley · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Investigating Extrachromosomal DNA (ecDNA) Segregation and Repair in Cancer
John Maciejowski · Kettering University · funded by National Institutes of Health
2025–2026 · research · R21
Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization
Mark Thomas Burgess · Kettering University · funded by National Institutes of Health
2025–2027 · research · R01
Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial
Jessica Scott · Kettering University · funded by National Institutes of Health
2025–2028 · fellowship · F32
Investigating the Role of Mutagenic DNA Repair during the Persistence of Cancer Cells
Megan Elizabeth Kelley · Kettering University · funded by National Institutes of Health
2025–2027 · career development · K99
Developing and Validating Prognostic Models for Black women with Endometrial Cancer following Hysterectomy
Noah Charles Peeri · Kettering University · funded by National Institutes of Health
2025–2027 · career development · K38
Predictive Markers of Response to and Treatment Effects of Motixafortide, Cemiplimab, Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Metastatic Pancreatic Cancer
Michael Stevenson May · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Jennifer Cf Leng · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Targeting the Epidermal Growth Factor Receptor (EGFR) to Revert Trastuzumab Deruxtecan Resistance in HER2-low Colorectal Cancer.
Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Mechanisms and therapeutic potential of the autophagy-lysosome pathway in Alzheimer’s disease
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2025–2027 · fellowship · F32
Cytoskeletal organization by Toll-like receptors during epithelial morphogenesis
Nathan Shugarts Devanapally · Kettering University · funded by National Institutes of Health
2025–2027 · research · R21
Electronic Nose Technology to Predict and Assess Pathologic Response After Neoadjuvant Therapy and Recurrence for Non-Small Cell Lung Cancer
Gaetano Rocco · Kettering University · funded by National Institutes of Health
2025–2027 · research · R37
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
Jessica Scott · Kettering University · funded by National Institutes of Health
2025–2030 · research · R50
Instituting NCI-funded thyroid and head and neck cancer studies
Eric Sherman · Kettering University · funded by National Institutes of Health
2025–2027 · research · R21
Bispecific antibodies in multiple myeloma: understanding therapy resistance through imaging
Vladimir Ponomarev · Kettering University · funded by National Institutes of Health
2025–2026 · fellowship · F99
Identifying and Targeting Drivers of Impaired Translation in Tumor-infiltrating CD8+ T-cells.
Yan-Ting Chen · Kettering University · funded by National Institutes of Health
2025 · research · R37
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · Kettering University · funded by National Institutes of Health
2025–2030 · research · R35
Mechanisms of Lipid Droplet Protein Targeting
Tobias C Walther · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Decoding disease-critical genomic architecture using multimodal single-cell omics data
Kushal Kumar Dey · Kettering University · funded by National Institutes of Health
2025–2028 · research · R33
Programmable nucleic acid cytometry for unraveling heterogeneity in tumors and therapies
Ronan Chaligne · Kettering University · funded by National Institutes of Health
2025–2030 · career development · K08
Genome instability associated with oncogene amplification and its therapeutic strategy
Jake June-Koo Lee · Kettering University · funded by National Institutes of Health
2025–2027 · research · R01
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
Yu Chen · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Inflammatory Signaling in the Leptomeninges
Adrienne A. Boire · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Investigating the role of Microhomology-Mediated End-Joining (MMEJ) in Mitosis and its impact on drug resistance
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Pilot Feasibility of DESCANSO: Cognitive Behavioral Therapy for Latino Cancer Patients to Treat the Symptom Cluster Depression, Insomnia and Fatigue
Eida Maria Castro · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Development of chimeric antigen receptor T cells targeting cell surface U5 snRNP for the treatment of acute myeloid leukemia
Anthony Folawuyi Daniyan · Kettering University · funded by National Institutes of Health
2025–2027 · research · R21
Targeting Chromosomal Instability in the Evolution of Resistance to Matched Therapies Against Colorectal Cancer to Extend Treatment Response
Rona Yaeger · Kettering University · funded by National Institutes of Health
2025–2032 · research · R35
Understanding and Targeting Aberrant RNA Splicing in Leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2025–2027 · career development · K99
Metabolically Reprogramming Hepatic Macrophages to Conquer Immune Desert Tumors
Liangliang Ji · Kettering University · funded by National Institutes of Health
2025–2027 · fellowship · F99
Interrogating drivers of plasticity in early lung cancer tumorigenesis and metastatic dormancy.
Klavdija Krause · Kettering University · funded by National Institutes of Health
2025–2026 · research · R37
Targeting stem-like cells and their niche in pancreatic cancer
Tuomas Tammela · Kettering University · funded by National Institutes of Health